NCT05661981 - GLYCAR Post Market Multicenter Study | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

October 9, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions

Congenital Premature Cardiac ClosureCardiac and Great Vessel Reconstruction and RepairPeripheral Vascular Reconstruction and Repair

Interventions

DEVICE

GLYCAR Pericardial Patch

The Glycar patches are intended to be used by surgeons specialized in the field of cardiovascular surgery. The patch is intended to be used for pericardial closure, or repair and/or reconstruction of cardiovascular structures by replacing missing tissue, reinforcing weakened tissue and providing extra strength to repair tissue during healing.

Trial Locations (4)

Unknown

Marie Lannelongue Hospital, Le Plessis-Robinson

Leipzig Heart Institute GmbH, Leipzig

German Heart Center Munich (Deutsches Herzzentrum München)- Adult Section, Munich

German Heart Center Munich (Deutsches Herzzentrum München)- Pediatric Section, Munich

All Listed Sponsors

lead

GLYCAR SA (Pty) Ltd

INDUSTRY